申请人:Hoechst Aktiengesellschaft
公开号:US04374990A1
公开(公告)日:1983-02-22
A compound having the general formula or an acid addition salt thereof ##STR1## in which formula R.sub.1 is selected from the group consisting of (A) an at least mononuclear heterocyclic group having 4 to 10 carbon atoms in the ring system bound to the group ##STR2## through a carbon atom and containing at least one oxygen, nitrogen or sulphur atom, (B) substitution products of (A) containing at least one substituent selected from the group consisting of halogen, trifluoromethyl, hydroxy, alkoxy of 1 to 3 carbon atoms, unsubstituted amino, amino substituted by up to two alkyl groups each having 1 to 3 carbon atoms and alkyl groups having 1 to 6 carbon atoms, X is oxygen, sulphur or an NH-group, Y is an alkylene group having 1 to 3 carbon atoms in the chain, or an alkylene group having 1 to 3 carbon atoms in the chain substituted by (a) up to 3 alkyl groups each having up to 3 carbon atoms and a total of not more than 8 carbon atoms, or (b) substituted by one or two phenyl groups, R.sub.2 is selected from the group consisting of (c) an at least mononuclear carbocyclic or heterocyclic group having 4 to 10 carbon atoms in the ring system, containing but one heteroatom in a ring, (D) substitution products of (C) containing at least one substituent selected from the group consisting of nitro, halogen, trifluoromethyl, alkyl having 1 to 6 carbon atoms, hydroxy, alkoxy having 1 to 3 carbon atoms, unsubstituted amino groups and amino groups substituted by up to two alkyl groups each having 1 to 3 carbon atoms, R.sub.3 is hydrogen or up to two substituents selected from alkyl groups having up to 2 carbon atoms and phenyl groups. n is 2 or 3; a process for its preparation and a pharmaceutical composition containing said compound (I).
该化合物具有通式或其酸加成盐##STR1## 在该式中,R.sub.1选自组成的群体中,该群体包括具有4到10个碳原子的至少单核杂环基团,该杂环基团通过碳原子与基团##STR2## 结合,并且至少含有一个氧、氮或硫原子,(B) 从(A)中选择的取代产物,其中至少包含一种取代基,所述取代基选自卤素、三氟甲基、羟基、1到3个碳原子的烷氧基、未取代的氨基、氨基取代物,每个取代物具有1到3个碳原子的烷基取代物和具有1到6个碳原子的烷基基团,X为氧、硫或NH基团,Y为具有1到3个碳原子的链状烷基基团,或者是具有1到3个碳原子的链状烷基基团,取代(a)最多3个碳原子的烷基基团和不超过8个碳原子的总和,或(b)被一个或两个苯基取代,R.sub.2选自具有4到10个碳原子的至少单核碳环或杂环基团,其中在一个环中仅含有一个杂原子,(D) 从(C)中选择的取代产物,其中至少包含一种取代基,所述取代基选自硝基、卤素、三氟甲基、具有1到6个碳原子的烷基、羟基、1到3个碳原子的烷氧基、未取代的氨基团和氨基团,每个取代物具有1到3个碳原子的烷基取代物,R.sub.3为氢或最多两个取代基,所述取代基选自具有最多2个碳原子的烷基和苯基。n为2或3;其制备方法和含有所述化合物(I)的药物组合物。